SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-004968
Filing Date
2017-05-04
Accepted
2017-05-04 17:23:58
Documents
51
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q Q1 2017 ARBUTUS BIOPHARMA CORP arbutusq12017.htm 10-Q 779629
2 EXHIBIT 31.1 exhibit311q12017.htm EX-31.1 13491
3 EXHIBIT 31.2 exhibit312q12017.htm EX-31.2 13973
4 EXHIBIT 32.1 exhibit321q12017.htm EX-32.1 6598
5 EXHIBIT 32.2 exhibit322q12017.htm EX-32.2 6939
12 Q1 2017 PIPELINE q12017pipeline2.jpg GRAPHIC 228198
  Complete submission text file 0001628280-17-004968.txt   3848630

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT abus-20170331.xml EX-101.INS 559350
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20170331.xsd EX-101.SCH 36310
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20170331_cal.xml EX-101.CAL 57080
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20170331_def.xml EX-101.DEF 141499
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20170331_lab.xml EX-101.LAB 403617
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20170331_pre.xml EX-101.PRE 223727
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 17815284
SIC: 2834 Pharmaceutical Preparations